Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Jul;66(3):358–360. doi: 10.1111/j.1476-5381.1979.tb10837.x

5-Hydroxytryptamine and myoclonus induced by 1,2-di-hydroxybenzene (catechol) in the guinea-pig.

D Chadwick, P Jenner, C D Marsden
PMCID: PMC2043656  PMID: 93500

Abstract

Myoclonus induced by catechol in the guinea-pig is not altered by manipulation of cerebral 5-hydroxytryptamine (5-HT). The administration of catechol does not alter brain levels of 5-HT or its metabolite 5-hydroxyindole acetic acid. This form of myoclonus therefore is not of relevance to the 5-HT-sensitive post-anoxic action myoclonus occurring in man.

Full text

PDF
358

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angel A. An analysis of the effect of 1,2-dihydroxybenzene on transmission through the dorsal column sensory pathway. Electroencephalogr Clin Neurophysiol. 1969 Oct;27(4):392–403. doi: 10.1016/0013-4694(69)91448-5. [DOI] [PubMed] [Google Scholar]
  2. Angel A., Clarke K. A., Dewhurst D. G. A pharmacological study of the spontaneous convulsive activity induced by 1,2-dihydroxybenzene (catechol) in the anaesthetized mouse. Br J Pharmacol. 1977 Nov;61(3):433–439. doi: 10.1111/j.1476-5381.1977.tb08437.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Angel A., Dewhurst D. G. A pharmacological investigation of the electrically evoked convulsive activity induced by administration of catechol in the anaesthetized rat. Br J Pharmacol. 1978 Dec;64(4):539–544. doi: 10.1111/j.1476-5381.1978.tb17315.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Angel A., Dewhurst D. G. Proceedings: Effects of cholinergic drugs on catechol evoked convulsions. J Physiol. 1976 Jan;254(1):36P–37P. [PubMed] [Google Scholar]
  5. Angel A., Lemon R. N. An analysis of the myoclonic jerks produced by 1, 2-dihydroxybenzene in the rat. Electroencephalogr Clin Neurophysiol. 1973 Dec;35(6):589–601. doi: 10.1016/0013-4694(73)90212-5. [DOI] [PubMed] [Google Scholar]
  6. Angel A., Lemon R. N. Sensorimotor cortical representation in the rat and the role of the cortex in the production of sensory myoclonic jerks. J Physiol. 1975 Jun;248(2):465–488. doi: 10.1113/jphysiol.1975.sp010984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Angel A., Lemon R. N. The convulsive action of 1,2-dihydroxybenzene in the anaesthetized rat. Electroencephalogr Clin Neurophysiol. 1973 Apr;34(4):369–378. doi: 10.1016/0013-4694(73)90088-6. [DOI] [PubMed] [Google Scholar]
  8. Chadwick D., Hallett M., Harris R., Jenner P., Reynolds E. H., Marsden C. D. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Brain. 1977 Sep;100(3):455–487. doi: 10.1093/brain/100.3.455. [DOI] [PubMed] [Google Scholar]
  9. Chadwick D., Hallett M., Jenner P., Marsden C. D. 5-hydroxytryptophan-induced myoclonus in guinea pigs. A physiological and pharmacological investigations. J Neurol Sci. 1978 Jan;35(1):157–165. doi: 10.1016/0022-510x(78)90108-9. [DOI] [PubMed] [Google Scholar]
  10. Curzon G., Green A. R. Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol. 1970 Jul;39(3):653–655. doi: 10.1111/j.1476-5381.1970.tb10373.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hwang E. C., Van Woert M. H. p,p'-DDT-induced neurotoxic syndrome: experimental myoclonus. Neurology. 1978 Oct;28(10):1020–1025. doi: 10.1212/wnl.28.10.1020. [DOI] [PubMed] [Google Scholar]
  12. Klawans H. L., Jr, Goetz C., Weiner W. J. 5-Hydroxytryptophan-induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus. Neurology. 1973 Nov;23(11):1234–1240. doi: 10.1212/wnl.23.11.1234. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES